The Use of Platelet-Rich Plasma in the Management of Foot and Ankle Conditions

Operative Techniques in Sports Medicine

Volumn 19, Issue 3, 2011, Pages 177-184

  Jia, Xiaofeng ^a   Peters, Paul G ^b   Schon, Lew ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNION MEMORIAL HOSPITAL   (United States)

Author keywords

Bone marrow aspiration; Bone marrow concentrate; Foot and ankle; Growth factor; Mesenchymal stem cells; Musculoskeletal; Platelet rich plasma

Indexed keywords

EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SCATTER FACTOR; THROMBOCYTE CONCENTRATE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANKLE FRACTURE; ANKLE INJURY; ARTHRITIS; ARTICLE; BONE MALFORMATION; FOOT DISEASE; FOOT SURGERY; FRACTURE NONUNION; HUMAN; ILIAC CREST; LIGAMENT INJURY; MORBIDITY; PLANTAR FASCIITIS; PRIORITY JOURNAL; PROXIMAL TIBIA FRACTURE; TENDINITIS; TENDON RUPTURE; THROMBOCYTE RICH PLASMA;

EID: 80052331312     PISSN: 10601872     EISSN: 15579794     Source Type: Journal    
DOI: 10.1053/j.otsm.2011.04.003     Document Type: Article

References (61)

1. Welch ZR, McKale JM, Woodell-May J: Citrate-based anticoagulant does not hinder stem cell viability and concentration from bone marrow aspirate. 54th Orthopedics Research Societies Annual Meeting, San Francisco, CA, 2008, March 2-5.
2. Woodell-May J.E., Ridderman D.N., Swift M.J., et al. Producing accurate platelet counts for platelet rich plasma: Validation of a hematology analyzer and preparation techniques for counting. J Craniofac Surg 2005, 16:749-756.
3. Cervelli V., Gentile P., Scioli M.G., et al. Application of platelet-rich plasma in plastic surgery: Clinical and in vitro evaluation. Tissue Eng C Methods 2009, 15:625-634.
4. Gentile P., Bottini D.J., Spallone D., et al. Application of platelet-rich plasma in maxillofacial surgery: Clinical evaluation. J Craniofac Surg 2010, 21:900-904.
5. Papa F., Cortese A., Sagliocco R., et al. Outcome of 47 consecutive sinus lift operations using aragonitic calcium carbonate associated with autologous platelet-rich plasma: Clinical, histologic, and histomorphometrical evaluations. J Craniofac Surg 2009, 20:2067-2074.
6. Gentile P., Bottini D.J., Spallone D., et al. Application of platelet-rich plasma in maxillofacial surgery: Clinical evaluation. J Craniofac Surg 2010, 21:900-904.
7. Foitzik C., Staus H. Le Fort I osteotomy in atrophied maxilla and bone regeneration with pure-phase beta-tricalcium phosphate and PRP. Implant Dent 2003, 12:132-139.
8. Thorn J.J., Sorensen H., Weis-Fogh U., et al. Autologous fibrin glue with growth factors in reconstructive maxillofacial surgery. Int J Oral Maxillofac Surg 2004, 33:95-100.
9. Tonelli P., Mannelli D., Brancato L., et al. Counting of platelet derived growth factor and transforming growth factor-beta in platelet-rich-plasma used in jaw bone regeneration. Minerva Stomatol 2005, 54:23-34.
10. Cervelli V., Lucarini L., Spallone D., et al. Use of platelet rich plasma and hyaluronic acid on exposed tendons of the foot and ankle. J Wound Care 2010, 19:188-190.
11. Akingboye A.A., Giddins S., Gamston P., et al. Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: Diabetic foot ulcer. J Extra Corpor Technol 2010, 42:20-29.
12. Almdahl S.M., Veel T., Halvorsen P., et al. Randomized prospective trial of saphenous vein harvest site infection after wound closure with and without topical application of autologous platelet-rich plasma. Eur J Cardiothorac Surg 2011, 39:44-48.
13. Knighton D.R., Ciresi K., Fiegel V.D., et al. Stimulation of repair in chronic, nonhealing, cutaneous ulcers using platelet-derived wound healing formula. Surg Gynecol Obstet 1990, 170:56-60.
14. Eppley B.L., Woodell J.E., Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: Implications for wound healing. Plast Reconstr Surg 2004, 114:1502-1508.
15. Hall M.P., Band P.A., Meislin R.J., et al. Platelet-rich plasma: Current concepts and application in sports medicine. J Am Acad Orthop Surg 2009, 17:602-608. http://www.jaaos.org.
16. Filardo G., Presti M.L., Kon E., et al. Nonoperative biological treatment approach for partial Achilles tendon lesion. Orthopedics 2010, 33:120-123.
17. Foster T.E., Puskas B.L., Mandelbaum B.R., et al. Platelet-rich plasma: From basic science to clinical applications. Am J Sports Med 2009, 37:2259-2272.
18. Creaney L., Hamilton B. Growth factor delivery methods in the management of sports injuries: The state of play. Br J Sports Med 2008, 42:314-320.
19. Sánchez M., Anitua E., Lopez-Vidriero E., et al. The future: Optimizing the healing environment in anterior cruciate ligament reconstruction. Sports Med Arthrosc 2010, 18:48-53.
20. Cheung E.V., Silverio L., Sperling J.W. Strategies in biologic augmentation of rotator cuff repair: A review. Clin Orthop Relat Res 2010, 468:1476-1484.
21. Hartmann E.K., Heintel T., Morrison R.H., et al. Influence of platelet-rich plasma on the anterior fusion in spinal injuries: A qualitative and quantitative analysis using computer tomography. Arch Orthop Trauma Surg 2010, 130:909-914.
22. Gaweda K., Tarczynska M., Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int J Sports Med 2010, 31:577-583.
23. Soomekh D.J. Using platelet-rich plasma in the foot and ankle. Foot Ankle Spec 2010, 3:88-90. http://fas.sagepub.com/.
24. Hardy M.A., Logan D.B. Principles of arthrodesis and advances in fixation for the adult acquired flatfoot. Clin Podiatr Med Surg 2007, 24:789-813.
25. de S., de Vos R.J., Weir A., et al. One-year Follow-up of Platelet-Rich Plasma Treatment in Chronic Achilles Tendinopathy: A Double-Blind Randomized Placebo-Controlled Trial. Am J Sports Med 2011, May 21, [Epub ahead of print].
26. de Vos R.J., Weir A., van Schie H.T., et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: A randomized controlled trial. JAMA 2010, 303:144-149.
27. Monto RR: Platelet rich plasma (PRP) effectively treats chronic Achilles tendinosis. The 77th Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS). New Orleans, LA, 2010, March 10-13.
28. Gaweda K., Tarczynska M., Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int J Sports Med 2010, 31:577-583.
29. Sanchez M., Anitua E., Azofra J., et al. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007, 35:245-251.
30. Schepull T., Kvist J., Norrman H., et al. Autologous platelets have no effect on the healing of human Achilles tendon ruptures: A randomized single-blind study. Am J Sports Med 2011, 39:38-47.
31. Swift MJ, Welch ZR, McKale JM, et al: Efficient harvest of a mononuclear cell-rich fraction from aspirated bone marrow: 53rd Annual Meeting of the Orthopaedic Research Society. San Diego, CA, 2007, February 11-14.
32. Crisostomo P.R., Wang Y., Markel T.A., et al. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappaB-but not JNK-dependent mechanism. Am J Physiol Cell Physiol 2008, 294:C675-C682.
33. Mendez-Ferrer S., Michurina T.V., Ferraro F., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
34. Yoshikawa T., Ueda Y., Miyazaki K., et al. Disc regeneration therapy using marrow mesenchymal cell transplantation: A report of two case studies. Spine (Phila Pa 1976) 2010, 35:E475-E480.
35. Kitchel S.H., Wang M.Y., Lauryssen C.L. Techniques for aspirating bone marrow for use in spinal surgery. Neurosurgery 2005, 57(suppl):286-289.
36. McLain R.F., Fleming J.E., Boehm C.A., et al. Aspiration of osteoprogenitor cells for augmenting spinal fusion: Comparison of progenitor cell concentrations from the vertebral body and iliac crest. J Bone Joint Surg Am 2005, 87:2655-2661.
37. Di Bella C., Dozza B., Frisoni T., et al. Injection of demineralized bone matrix with bone marrow concentrate improves healing in unicameral bone cyst. Clin Orthop Relat Res 2010, 468:3047-3055.
38. Wright J.G., Yandow S., Donaldson S., et al. A randomized clinical trial comparing intralesional bone marrow and steroid injections for simple bone cysts. J Bone Joint Surg Am 2008, 90:722-730.
39. Arazi M., Senaran H., Memik R., et al. Minimally invasive treatment of simple bone cysts with percutaneous autogenous bone marrow injection. Orthopedics 2005, 28:108-112.
40. Tseng S.S., Lee M.A., Reddi A.H. Nonunions and the potential of stem cells in fracture-healing. J Bone Joint Surg Am 2008, 90(suppl 1):92-98.
41. Connolly J.F. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop Relat Res 1995, 313:8-18.
42. Connolly J.F., Guse R., Tiedeman J., et al. Autologous marrow injection for delayed unions of the tibia: A preliminary report. J Orthop Trauma 1989, 3:276-282.
43. Bielecki T., Gazdzik T.S., Szczepanski T. Benefit of percutaneous injection of autologous platelet-leukocyte-rich gel in patients with delayed union and nonunion. Eur Surg Res 2008, 40:289-296.
44. Bajada S., Harrison P.E., Ashton B.A., et al. Successful treatment of refractory tibial nonunion using calcium sulphate and bone marrow stromal cell implantation. J Bone Joint Surg Br 2007, 89:1382-1386.
45. Hernigou P., Mathieu G., Poignard A., et al. Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique. J Bone Joint Surg Am 2006, 88(suppl 1):322-327.
46. Hernigou P., Poignard A., Beaujean F., et al. Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells. J Bone Joint Surg Am 2005, 87:1430-1437.
47. Hernigou P., Poignard A., Manicom O., et al. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br 2005, 87:896-902.
48. Connolly J.F., Guse R., Tiedeman J., et al. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 1991, 266:259-270.
49. Healey J.H., Zimmerman P.A., McDonnell J.M., et al. Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Orthop Relat Res 1990, 256:280-285.
50. Pinzur M.S. Use of platelet-rich concentrate and bone marrow aspirate in high-risk patients with Charcot arthropathy of the foot. Foot Ankle Int 2009, 30:124-127.
51. Prochazka V., Gumulec J., Jaluvka F., et al. Cell therapy, a new standard in management of chronic critical limb ischemia and foot ulcer. Cell Transplant 2010, 19:1413-1424.
52. Ishigatsubo Y., Ihata A., Kobayashi H., et al. Therapeutic angiogenesis in patients with systemic sclerosis by autologous transplantation of bone-marrow-derived cells. Mod Rheumatol 2010, 20:263-272.
53. Giannini S., Buda R., Vannini F., et al. One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res 2009, 467:3307-3320.
54. Courneya J-P, Luzina IG, Orlov MD, et al: Bone marrow stem cells heal tendon via secreted factors: World Stem Cell Summit, Baltimore, MD, 2009, September 21-23.
55. Chong A.K., Ang A.D., Goh J.C., et al. Bone marrow-derived mesenchymal stem cells influence early tendon-healing in a rabbit Achilles tendon model. J Bone Joint Surg Am 2007, 89:74-81.
56. Han S.H., Lee J.W., Guyton G.P., et al. Leonard Goldner Award 2008. Effect of extracorporeal shock wave therapy on cultured tenocytes. Foot Ankle Int 2009, 30:93-98.
57. Han B., Woodell-May J., Ponticiello M., et al. The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity. J Bone Joint Surg Am 2009, 91:1459-1470.
58. Schon LC, Gamez L, Dunn R: Cell concentrate from autologous bone marrow augments bone grafting in the lower extremity. American Orthopaedic Foot and Ankle Society 26th Annual Summer Meeting, National Harbor, MD, 2010 July 7-10.
59. Lau J.T., Stamatis E.D., Myerson M.S., et al. Implantable direct-current bone stimulators in high-risk and revision foot and ankle surgery: A retrospective analysis with outcome assessment. Am J Orthop (Belle Mead NJ) 2007, 36:354-357.
60. Sammarco V.J., Sammarco G.J., Walker E.W., et al. Midtarsal arthrodesis in the treatment of Charcot midfoot arthropathy. Surgical technique. J Bone Joint Surg Am 2010, 92(suppl 1):1-19.
61. Assal M., Stern R. Realignment and extended fusion with use of a medial column screw for midfoot deformities secondary to diabetic neuropathy. J Bone Joint Surg Am 2009, 91:812-820.